サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：タンパク質発現の世界市場：市場規模、シェア、動向分析、機会、予測 - システムタイプ別、用途別、エンドユーザー別、地域別（2019年～2029年）
市場調査レポート
商品コード
1227606

タンパク質発現の世界市場：市場規模、シェア、動向分析、機会、予測 - システムタイプ別、用途別、エンドユーザー別、地域別（2019年～2029年）

Protein Expression Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By System Type ; By Application ; By End User ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
タンパク質発現の世界市場：市場規模、シェア、動向分析、機会、予測 - システムタイプ別、用途別、エンドユーザー別、地域別（2019年～2029年）
出版日: 2023年02月17日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のタンパク質発現の市場規模は、2022年に31億2,000万米ドルとなり、2029年には71億6,000万米ドルに達し、2023年～2029年の予測期間中にCAGRで12.63%の成長が予測されています。

世界市場は、バイオ医薬品企業によるタンパク質発現の研究開発への投資の増加や、組換えベースのタンパク質発現の採用が進んでいることにより、活性化しています。

当レポートでは、世界のタンパク質発現市場について調査し、市場の洞察、市場概要、地域別の市場分析、競合情勢、企業プロファイル等に関する情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界のタンパク質発現市場の洞察

  • 産業バリューチェーン分析
  • DROC分析
    • 促進要因
      • タンパク質生物製剤の需要の増加
      • 医薬品・バイオ医薬品産業における研究開発の増加
      • 組換えベースのタンパク質発現の採用が拡大
      • タンパク質ベースの研究における資金の利用可能性
    • 抑制要因
      • タンパク質発現の試薬・機器の高コスト
      • 統合が進み、新規参入に対する高い障壁
    • 機会
      • マイクロフルイディクスの出現
      • 大きな成長の可能性を秘めた新興経済国
    • 課題
      • 望ましくないトランスレーション後の改変と精製
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入者の脅威
    • 代替品の脅威
    • 競合の激しさ

第4章 世界のタンパク質発現の市場概要

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
      • 哺乳類細胞発現システム
      • 原核生物発現システム
      • 昆虫細胞発現システム
      • 酵母発現システム
      • 無細胞発現システム
      • 藻類ベースの発現システム
    • 用途別
      • 治療
      • 研究
      • 工業
    • エンドユーザー別
      • 製薬・バイオテクノロジー企業
      • 受託調査機関・受託開発製造機関（CROS・CDMOS）
      • 学術研究機関
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第5章 北米のタンパク質発現市場

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州のタンパク質発現市場

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • オランダ
      • その他の欧州

第7章 アジア太平洋のタンパク質発現市場

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア・ニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • フィリピン
      • ベトナム
      • その他のアジア太平洋

第8章 ラテンアメリカのタンパク質発現市場

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • コロンビア
      • その他のラテンアメリカ

第9章 中東・アフリカのタンパク質発現市場

  • 市場規模・予測、2019年～2029年
    • 金額別（10億米ドル）
  • 市場シェア・予測
    • システムタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他の中東・アフリカ

第10章 競合情勢

  • 主要企業と製品リスト
  • 世界のタンパク質発現企業の市場シェア分析、2022年
  • 競合ベンチマーキング：運用パラメーター別
  • 主要な戦略的開発（合併、買収、パートナーシップなど）

第11章 世界のタンパク質発現市場におけるCOVID-19の影響

第12章 企業プロファイル（企業概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、SWOT分析）

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Agilent Technologies, Inc.
  • Takara Bio, Inc.
  • Bio-Rad Laboratories, Inc
  • Qiagen N.V
  • Charles River Laboratories, Inc.
  • Danaher Corporation
  • Sartorius AG
  • Corning Incorporated
  • FUJIFILM Irvine Scientific, Inc.
  • Lonza Group AG
  • Bioneer Corporation
  • Promega Corporation
  • Oxford Expression Technologies Ltd
  • その他の有力企業

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23135

Global Protein Expression Market Size More Than Doubles to Reach USD 7.2 Billion by 2029.

The global protein expression market is gaining traction because of the increasing investments in R&D protein expression by biopharmaceutical companies and growing adoption of recombinant-based protein expression.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global protein expression market size at USD 3.12 billion in 2022. During the forecast period between 2023 and 2029, the global protein expression market size is projected to grow at an impressive CAGR of 12.63% reaching a value of USD 7.16 billion by 2029. The growing use of protein expression in the biopharmaceutical and life sciences sector for the development of novel medications and treatments is one of the major growth reasons for the global protein expression market. Protein expression is the subject of intensive research and development efforts as a result of the rising incidence of cancer and other chronic diseases throughout the world, which is fueling the market's expansion.

Global Protein Expression Market - Overview:

The process through which proteins are created, altered, and controlled in living organisms is referred to as protein expression. The analysis of protein expression in cancer cells may provide details about a particular type of cancer, the optimal course of treatment, and the effectiveness of a particular course of treatment. For further studies, such as identifying the three-dimensional structure of proteins, as chemical instruments or probes, or as novel classes of pharmaceuticals, among others, expressed protein products that are functional and exhibit traits comparable to their native counterparts are helpful.

Global Protein Expression Market - By End User:

Based on end users, the global protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract development and manufacturing organizations (CROs and CDMOs), academic research institutes, and others. The pharmaceutical and biotechnology company segment accounts for the highest market share. Protein expression is widely used in pharmaceutical and biotechnology companies to carry out research and develop new drugs. CROs are also gaining traction owing to increasing outsourcing of research activities at lower costs which helps companies increase their profit margins.

Impact of COVID-19 on Global Protein Expression Market

The unprecedented COVID-19 pandemic outbreak brought various growth opportunities for the global protein expression market. According to earlier research, the novel coronavirus infects people via infecting epithelial cells by connecting with the human ACE2 receptor protein on their surface. As a result, extensive research activities surrounding the study of the protein expression status of angiotensin-converting enzyme 2 (ACE2) to understand the hypothesized correlation of the level of ACE2 expression in lungs with an increased risk of severe infection and complications in COrona VIrus Disease 2019 (COVID-19). Several other types of research like these with the application of protein expression also played a crucial role in tackling the COVID-19 pandemic.

Competitive Landscape:

Major players operating in the global Protein Expression market include: Thermo Fisher Scientific, Inc., Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Inc., Takara Bio, Inc., Bio-Rad Laboratories, Inc, Qiagen N.V, Charles River Laboratories, Inc., Danaher Corporation, Sartorius AG, Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Lonza Group AG, Bioneer Corporation, Promega Corporation, and Oxford Expression Technologies Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Protein Expression Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Protein Expression Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Protein Expression Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Protein Expression Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing demand for protein biologics
      • 3.2.1.2. Increasing R&D in pharmaceutical and biopharmaceutical industries
      • 3.2.1.3. Growing adoption of recombinant-based protein expression
      • 3.2.1.4. Availability of funding for protein-based research
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of protein expression reagents and instruments
      • 3.2.2.2. Increasing consolidation and high barriers for new entrants
    • 3.2.3. Opportunities
      • 3.2.3.1. Emergence of microfluidics
      • 3.2.3.2. Emerging economies offering significant growth potential
    • 3.2.4. Challenges
      • 3.2.4.1. Undesired post-translational modifications and purification
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Protein Expression Market Overview

  • 4.1. Market Size & Forecast by Value, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By System Type
      • 4.2.1.1. Mammalian Cell Expression Systems
      • 4.2.1.2. Prokaryotic expression systems
      • 4.2.1.3. Insect cell expression systems
      • 4.2.1.4. Yeast expression systems
      • 4.2.1.5. Cell-free expression systems
      • 4.2.1.6. Algal-based expression systems
    • 4.2.2. By Application
      • 4.2.2.1. Therapeutic
      • 4.2.2.2. Research
      • 4.2.2.3. Industrial
    • 4.2.3. By End User
      • 4.2.3.1. Pharmaceutical and Biotechnology companies
      • 4.2.3.2. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)
      • 4.2.3.3. Academic Research Institutes
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Protein Expression Market

  • 5.1. Market Size & Forecast by Value, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By System Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. US
      • 5.2.4.1.1. By System Type
      • 5.2.4.1.2. By Application
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By System Type
      • 5.2.4.2.2. By Application
      • 5.2.4.2.3. By End User

6. Europe Protein Expression Market

  • 6.1. Market Size & Forecast by Value, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By System Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By System Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By End User
      • 6.2.4.2. UK
      • 6.2.4.2.1. By System Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By System Type
      • 6.2.4.3.2. By Application
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By System Type
      • 6.2.4.4.2. By Application
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By System Type
      • 6.2.4.5.2. By Application
      • 6.2.4.5.3. By End User
      • 6.2.4.6. The Netherlands
      • 6.2.4.6.1. By System Type
      • 6.2.4.6.2. By Application
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Rest of Europe
      • 6.2.4.7.1. By System Type
      • 6.2.4.7.2. By Application
      • 6.2.4.7.3. By End User

7. Asia Pacific Protein Expression Market

  • 7.1. Market Size & Forecast by Value, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By System Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By System Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By System Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By System Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By System Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By System Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By System Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By System Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By System Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Philippines
      • 7.2.4.9.1. By System Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Vietnam
      • 7.2.4.10.1. By System Type
      • 7.2.4.10.2. By Application
      • 7.2.4.10.3. By End User
      • 7.2.4.11. Rest of APAC
      • 7.2.4.11.1. By System Type
      • 7.2.4.11.2. By Application
      • 7.2.4.11.3. By End User

8. Latin America Protein Expression Market

  • 8.1. Market Size & Forecast by Value, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By System Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By System Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By System Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By System Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By System Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Colombia
      • 8.2.4.5.1. By System Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By End User
      • 8.2.4.6. Rest of LATAM
      • 8.2.4.6.1. By System Type
      • 8.2.4.6.2. By Application
      • 8.2.4.6.3. By End User

9. Middle East & Africa Protein Expression Market

  • 9.1. Market Size & Forecast by Value, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By System Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By System Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By System Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By System Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By System Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By System Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By System Type
      • 9.2.4.6.2. By Application
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By System Type
      • 9.2.4.7.2. By Application
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By System Type
      • 9.2.4.8.2. By Application
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Protein Expression Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Protein Expression Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Merck KGaA
  • 12.3. GenScript Biotech Corporation
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Takara Bio, Inc.
  • 12.6. Bio-Rad Laboratories, Inc
  • 12.7. Qiagen N.V
  • 12.8. Charles River Laboratories, Inc.
  • 12.9. Danaher Corporation
  • 12.10. Sartorius AG
  • 12.11. Corning Incorporated
  • 12.12. FUJIFILM Irvine Scientific, Inc.
  • 12.13. Lonza Group AG
  • 12.14. Bioneer Corporation
  • 12.15. Promega Corporation
  • 12.16. Oxford Expression Technologies Ltd
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumption & Limitation